Pharmacy Ingredient Supplier Pays $22M For Reporting Inflated Wholesale Prices
WASHINGTON, D.C. — The U.S. Justice Department on Nov. 7 announced that Fagron Holding USA LLC agreed to pay $22.05 million to resolve allegations that subsidiary Freedom Pharmaceuticals Inc. reported inflated...To view the full article, register now.
Already a subscriber? Click here to view full article